31
Participants
Start Date
January 12, 2023
Primary Completion Date
June 4, 2025
Study Completion Date
June 4, 2025
Bempedoic acid
Once daily oral dosing with oral tablets.
Rigshospitalet, Copenhagen
Corporacio Sanitaria Parc Tauli - Hospital de Sabadell, Barcelona
Hospital Sant Joan de Deu, Barcelona
Hospital Universitario de Jerez de la Frontera, Cadiz
Hospital Universitario Reina Sofia, Córdoba
Hospital Abente y Lago, A Coruña
Cardiology Care for Children, Lancaster
Wake Forest University Health Sciences, Winston-Salem
Hospital Universitario Ramon y Cajal, Madrid
Excel Medical Clinical Trials, LLC, Boca Raton
Cincinnati Children's Hospital Medical Center, Cincinnati
Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research, St Louis
University of Utah and Primary Children's Hospital, Salt Lake City
Cedars-Sinai Medical Center, Los Angeles
Providere Research Inc, West Covina
University of Alberta Hospital - Stollery Children's Hospital, Edmonton
McMaster University Medical Center, Hamilton
Ecogene-21, Chicoutimi
Viborg Regional Hospital, Viborg
Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet, Frankfurt am Main
Kinder- und Jugendkrankenhaus AUF DER BULT, Hanover
Hospital Universitario 12 de Octubre, Madrid
Amsterdam UMC - Locatie AMC, Amsterdam
Erasmus MC, Rotterdam
Lead Sponsor
Esperion Therapeutics, Inc.
INDUSTRY